Patents by Inventor John Beals

John Beals has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12535395
    Abstract: A system for pipeline testing uses an electronics control module to monitor remote sensor data and compare the remote sensor data to control parameter input data that includes data indicating acceptable testing parameter ranges. In response to the comparison of the real time sensor data and the control parameter input data, the electronics control module generates various control signals used to control an automated fluid control system to regulate the pressure in the pipeline being tested and, if necessary, instigate an emergency shutdown of the test and to release all pressure from the section of pipe being tested. All test data is recorded, stored, and made available as needed/desired.
    Type: Grant
    Filed: September 15, 2023
    Date of Patent: January 27, 2026
    Assignee: Blue Sky Construction, LLC
    Inventors: Jodie Carlile, John Beals
  • Publication number: 20070142278
    Abstract: The present invention relates to novel muteins of human fibroblast growth factor 21 with improved pharmaceutical properties. Both protein and the respective encoding nucleic acid species are disclosed. The invention also embodies vectors and host cells for the propagation of said nucleic acid sequences and the production of said muteins. Also disclosed are methods for treating type 2 diabetes, obesity, metabolic syndrome, and in reducing the mortality and morbidity of critically ill patients.
    Type: Application
    Filed: December 1, 2004
    Publication date: June 21, 2007
    Inventors: John Beals, Christopher Frye, Wolfgang Glaesner, Shun Li, Radhakrishnan Rathnachalam, Jing Shang, Beth Strifler, Radmila Micanovic
  • Publication number: 20070100133
    Abstract: The present invention addresses the need for better pharmaceutical agents for teating anemias by providing polymer derivatized non-glycosylated erythropoietic compounds which show stability and bioactivity in vivo. The invention further provides methods for preparing these derivatived proteins which involves the use of a linkerless aldehyde modification process.
    Type: Application
    Filed: September 14, 2006
    Publication date: May 3, 2007
    Inventors: John Beals, Wolfgang Glaesner, Radmila Micanovic, Rohn Millican, Derrick Witcher
  • Publication number: 20060239789
    Abstract: A clip or bracket releasably mountable to a rail having elongated perforations to retain one or more items in a stored position when not in use. In a simple embodiment, the clip is formed of a continuous length of metal or plastic rod having a pair of parallel legs for insertion through the mounting rail perforation, and a three-sided enclosure which, in cooperation with the surface of the mounting rail, form a four-sided enclosure for retaining the stored item. In a second, preferred embodiment, a bracket is formed with an integral, three-sided wall with one or more latching members affixed to one of the walls for releasably attaching the bracket to the mounting rail with portions of the latching member(s) extending through one of the perforations. In one form, a pair of three-sided retainers are connected to one another with latching member(s) mounted between adjacent walls of the two retainers.
    Type: Application
    Filed: May 16, 2005
    Publication date: October 26, 2006
    Inventors: John Beals, David Jamieson, Thomas Haynes
  • Publication number: 20050070692
    Abstract: The present invention encompasses analogs of humanized antibody Hu007 that neutralize IL-1? activity in vivo. These antibodies can be used to treat various diseases such as rheumatoid arthritis and osteoarthritis.
    Type: Application
    Filed: February 20, 2003
    Publication date: March 31, 2005
    Inventors: John Beals, Lihua Huang, Jirong Lu, Derrick Witcher
  • Publication number: 20050014679
    Abstract: The present invention provides an insulin molecule that provides a protracted, even basal duration of action. The insulin molecule comprises a modification at the N-terminus of the A-chain, optionally a modification at the N-terminus of the B-chain, a modification at a B-chain lysine, and optionally a modification at the C-terminus of the A-chain. The present invention also provides a method of treating diabetes mellitus comprising administering the insulin molecule.
    Type: Application
    Filed: December 12, 2002
    Publication date: January 20, 2005
    Inventors: John Beals, Michael DeFelippis, Richard DiMarchi, Wayne Kohn, Radmila Micanovic, Sharon Myers, Kingman Ng, Lianshan Zhang